With bad news continuing to pile onto the stock, C3.ai stock has not only plunged to a new 52-week low, it has hit levels it ...

C3.ai Inc. closed 61.45% below its 52-week high of $45.08, which the company reached on December 10th.

C3.ai, Inc. AI stock has experienced a significant decline, declining 42.2% over the past month. In fact, AI stock fell ...

C3.ai, Inc. (AI) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider ...

C3.ai stock is down 80% from all-time highs and remains vulnerable due to widening losses and slowing revenue growth. Is it time to sell AI stock?

C3.ai, Inc. (NYSE:AI) is one of the AI Stocks Investors Are Watching Right Now. On August 13, Oppenheimer analyst Timothy ...

OpenAI CEO Sam Altman isn't alone in thinking that investors are overhyping AI.

C3.ai, Inc. (AI) concluded the recent trading session at $16.94, signifying a -2.53% move from its prior day's close.

The firm further anticipates that agentic AI, particularly software-based applications, will likely have “a broader impact on ...

C3.ai, Inc. AI recently announced a partnership with Eletrobras — Latin America’s largest power utility — to scale its Grid ...

Investing.com -- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stock surged 23% after the FDA lifted a clinical hold on the company’s pivotal Phase 2 trial of RP-A501 for the treatment of Danon disease.

In 2030, Berkshire will likely remain a durable pillar of investment stability. Meanwhile, Tesla and Palantir may dazzle ...